Clinical Trial Update: Effect of EPA on Aerobic Performance, Muscle, and Quality of Life in Colorectal Cancer Surgery Patients [Phase 2, Phase 3]

View source ↗

Summary

This clinical trial evaluates whether EPA (eicosapentaenoic acid) supplementation improves aerobic performance, muscle outcomes, and quality of life in colorect…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• EPA (eicosapentaenoic acid) (eicosapentaenoic acid)

Snippet

Sponsor: University of Nottingham | Conditions: Colorectal Cancer | Phase 2, Phase 3 | Status: UNKNOWN